These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7573092)

  • 1. The effect of fasting status on the determination of low-density and high-density lipoprotein cholesterol.
    Wilder LB; Bachorik PS; Finney CA; Moy TF; Becker DM
    Am J Med; 1995 Oct; 99(4):374-7. PubMed ID: 7573092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein-cholesterol analysis during screening: accuracy and reliability.
    Bachorik PS; Cloey TA; Finney CA; Lowry DR; Becker DM
    Ann Intern Med; 1991 May; 114(9):741-7. PubMed ID: 2012356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma fasting and nonfasting triglycerides and high-density lipoprotein cholesterol in atherosclerotic stroke: different profiles according to low-density lipoprotein cholesterol.
    Kim SJ; Park YG; Kim JH; Han YK; Cho HK; Bang OY
    Atherosclerosis; 2012 Aug; 223(2):463-7. PubMed ID: 22683121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonfasting non-high-density lipoprotein cholesterol is adequate for lipid management in hemodialysis patients.
    Desmeules S; Arcand-Bossé JF; Bergeron J; Douville P; Agharazii M
    Am J Kidney Dis; 2005 Jun; 45(6):1067-72. PubMed ID: 15957136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of Non-Fasting Lipid Profile for the Assessment of Lipoprotein Coronary Risk.
    Fatima S; Ijaz A; Sharif TB; Khan DA; Siddique A
    J Coll Physicians Surg Pak; 2016 Dec; 26(12):954-957. PubMed ID: 28043305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction.
    Langsted A; Freiberg JJ; Nordestgaard BG
    Circulation; 2008 Nov; 118(20):2047-56. PubMed ID: 18955664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fasting and nonfasting lipids--secondary publication].
    Langsted A; Freiberg JJ; Nordestgaard BG
    Ugeskr Laeger; 2009 Jun; 171(26):2184-7. PubMed ID: 19678434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct measurement of LDL-C in children: performance of two surfactant-based methods in a general pediatric population.
    Yu HH; Markowitz R; De Ferranti SD; Neufeld EJ; Farrow G; Bernstein HH; Rifai N
    Clin Biochem; 2000 Mar; 33(2):89-95. PubMed ID: 10751585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
    Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A
    Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homogeneous Assays for LDL-C and HDL-C are Reliable in Both the Postprandial and Fasting State.
    Miida T; Nishimura K; Hirayama S; Miyamoto Y; Nakamura M; Masuda D; Yamashita S; Ushiyama M; Komori T; Fujita N; Yokoyama S; Teramoto T
    J Atheroscler Thromb; 2017 Jun; 24(6):583-599. PubMed ID: 28321014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasting Versus Nonfasting and Low-Density Lipoprotein Cholesterol Accuracy.
    Sathiyakumar V; Park J; Golozar A; Lazo M; Quispe R; Guallar E; Blumenthal RS; Jones SR; Martin SS
    Circulation; 2018 Jan; 137(1):10-19. PubMed ID: 29038168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Extended-Release Niacin on High-Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin-Treated Patients.
    Yadav R; Liu Y; Kwok S; Hama S; France M; Eatough R; Pemberton P; Schofield J; Siahmansur TJ; Malik R; Ammori BA; Issa B; Younis N; Donn R; Stevens A; Durrington P; Soran H
    J Am Heart Assoc; 2015 Sep; 4(9):e001508. PubMed ID: 26374297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.
    J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Postprandial changes of blood lipid after ordinary Chinese diet and the influencing factors thereof].
    Fu ZF; Liu ML
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):260-2. PubMed ID: 19552844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening with total cholesterol: determining sensitivity and specificity of the National Cholesterol Education Program's guidelines from a population survey.
    Gelskey DE; Young TK; MacDonald SM
    J Clin Epidemiol; 1994 May; 47(5):547-53. PubMed ID: 7730880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes.
    Diekman MJ; Anghelescu N; Endert E; Bakker O; Wiersinga WM
    J Clin Endocrinol Metab; 2000 May; 85(5):1857-62. PubMed ID: 10843165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects.
    Schaefer EJ; McNamara JR; Tayler T; Daly JA; Gleason JA; Seman LJ; Ferrari A; Rubenstein JJ
    Am J Cardiol; 2002 Oct; 90(7):689-96. PubMed ID: 12356379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishing cut-off values for apolipoprotein B and non-HDL-C according to LDL-C values in a South European population.
    Martinez-Hervas S; Real JT; Priego MA; Carratalá A; Sniderman AD; Carmena R; Ascaso JF
    Int J Clin Pract; 2013 Jan; 67(1):81-8. PubMed ID: 23241052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.